US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 397.270
  • +0.630+0.16%
Close Dec 20 16:00 ET
  • 394.850
  • -2.420-0.61%
Post 20:01 ET
102.31BMarket Cap-209.09P/E (TTM)

Vertex Pharmaceuticals Key Stats

Vertex Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 4, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
2.69B
2.77B
+81.58M
Beat Est.
+8.33%
+11.61%
+3.03%
EPS
3.63
4.01
+0.38
Beat Est.
-8.55%
+1.01%
+10.45%
Buy

Dec 21, 2024

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.799B--
--2024/Q4-- / 2.784B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.799B--
--2024/Q4-- / 2.784B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 21, 2024

Buy

  • Buy

    61.29%
  • Hold

    32.26%
  • Sell

    6.45%

Price Target

No Data